Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Mirum Pharmaceuticals: Clinical Trials & FDA Approval Profile

Mirum Pharmaceuticals (Global / Institutional) sponsors 16 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 8 active protocols (3 recruiting now), 6 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)12.5%
Median Closed Enrollment vs National (145 pts)75 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Mirum Pharmaceuticals
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)16
Active Pipeline (Recruiting Now)8 (3)
Completed vs Stopped Early6 / 2 (12.5%)
Median Closed Actual Enrollment75 participants
Physical Hospital Site Disclosure97.9% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Mirum Pharmaceuticals
Hospital Research SiteLocationShared Protocols
King's College Hospital NHS Foundation TrustLondon6
Cliniques Universitaires Saint-LucBrussels5
UC Davis Comprehensive Cancer CenterSacramento, CA4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Mirum Pharmaceuticals
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07209462Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Phase IIRECRUITING
NCT04663308A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing ChoPhase IIACTIVE NOT RECRUITING
NCT06553768Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)Phase IIIACTIVE NOT RECRUITING
NCT04718961A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHPhase IITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the Mirum Pharmaceuticals Interactive Dossier, benchmark peers in Gastroenterology, Hepatology, and Renal, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI